当前位置: X-MOL 学术Curr. Pharm. Anal. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Ultrafiltration-based Extraction and LC-MS/MS Quantification of Phenylalanine in Human Blood Sample for Metabolite Target Analysis
Current Pharmaceutical Analysis ( IF 0.6 ) Pub Date : 2020-12-31 , DOI: 10.2174/1573412915666190715095300
Mustafa Çelebier 1 , Tuba Reçbera 1 , Emirhan Nemutlu 1 , Sedef Kır 1
Affiliation  

Background: Phenylalanine is a significant biomarker for various diseases like phenylketonuria, gastric cancers, and ischemic stroke according to recent studies.

Method: In the present study; a simple, sensitive, selective and novel analytical method was validated by using an ultrafiltration-based extraction and LC-MS/MS quantification of phenylalanine in human plasma using 13C phenylalanine heavy isotope. Amicon® Ultra Centrifugal Filter was used for ultrafiltration. Parameters affecting LC separation and MS/MS detection were investigated and optimized. Chromatographic separation was achieved on a Merck SeQuant ZIC-HILIC (100x4.6 mm, 5 μm) at a column temperature of 40°C using a mobile phase of mixture of acetonitrile containing 0.1% formic acid and water containing 0.1% formic acid (50:50 v/v) at a flow rate of 0.35 mL/min. The transitions m/z 167→121 for 13C phenylalanine, m/z 166→120 for phenylalanine itself were monitored using the MRM mode.

Result: The assay was linear concentration range of 0.0025 μg/mL to 1.20 μg/mL (R2=0.999). The developed method was validated according to FDA guidelines. The method was found linear, sensitive, precise, accurate, and selective.



中文翻译:

基于超滤的萃取和LC-MS / MS定量分析人血样品中的苯丙氨酸以用于代谢物目标分析

背景:根据最近的研究,苯丙氨酸是苯丙酮尿症,胃癌和缺血性中风等多种疾病的重要生物标志物。

方法:在本研究中;一种简单,灵敏,选择性和新颖的分析方法,通过使用基于13 C苯丙氨酸重同位素的超滤提取方法和LC-MS / MS定量测定人血浆中的苯丙氨酸进行了验证。Amicon®超离心过滤器用于超滤。研究和优化了影响液相色谱分离和MS / MS检测的参数。色谱分离是在Merck SeQuant ZIC-HILIC(100x4.6 mm,5μm)色谱柱上,在柱温为40°C的条件下进行的,其中使用的是含有0.1%甲酸的乙腈和含有0.1%甲酸的水(50 :50 v / v),流速为0.35 mL / min。m / z 167→121的过渡13使用MRM模式监测苯丙氨酸的C苯丙氨酸,m / z 166→120。

结果:该测定的线性浓度范围为0.0025μg/ mL至1.20μg/ mL(R 2 = 0.999)。根据FDA指南验证了开发的方法。发现该方法是线性的,灵敏的,精确的,准确的和选择性的。

更新日期:2020-11-23
down
wechat
bug